WHAT: Cenduit, LLC, the largest interactive response technology (IRT) specialist in the world, is showcasing its solutions and expertise at IRT Europe, April 4-5 in London, England. Cenduit’s Associate Director of Account Management Dan Pavitt will be speaking at the conference, discussing a hybrid approach to balancing standardization and flexibility in adaptive design for complex clinical trials.
With rapid study startup software, clinical supply chain intelligence, clinical operations know-how and customer-centric CORE teams, Cenduit ensures study needs are met on time and within budget. Other IRT-driven services include patient randomization and trial supply management (RTSM), integration, patient engagement and materials forecasting.
Attendees at IRT Europe are invited to stop by the Cenduit booth to learn how the company’s IRT solutions can help sponsors increase efficiencies, ensuring their study needs are met on time and within budget.
WHO: Dan Pavitt, Associate Director, Account Management
Salvo San Paolo, Senior Project Manager
David Horsley, Business Development Director
Laetitia Soudanas, Business Development Manager
Stacy Gletzakos, Global Head of Business Development, Account Management and Marketing
WHEN: Tuesday, April 4 – Wednesday, April 5, 2017
WHERE: Hilton London Paddington
146 Praed Street
London, W2 1EE, UK
DETAILS: For media inquiries, please contact Greyson Feurer at Largemouth Communications, (919) 459-6460, greyson@largemouthpr.com.
ABOUT: Cenduit, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.
